uPAR (I−III) was significantly associated with gender, uPAR (I−III) + uPAR (II−III) was significantly associated with gender, pathologic stage and resection margin, whereas uPAR(I) was significantly associated with gender and lymph node metastases. This evidence concerns the gene PLAUR and metastatic malignant neoplasm in the lymph nodes.